Navigation Links
ISTA Pharmaceuticals to Present at the Ninth Annual JMP Securities Research Conference
Date:5/4/2010

IRVINE, Calif., May 4 /PRNewswire-FirstCall/ -- ISTA Pharmaceuticals, Inc. (Nasdaq: ISTA), today announced it will present at the Ninth Annual JMP Securities Research Conference at 2:30 pm Pacific Time on May 12, 2010, in San Francisco, CA. ISTA's Chief Financial Officer and Vice President of Corporate Development Lauren Silvernail will provide an update on the Company's marketed products and clinical programs.

The presentation will be webcast. To access the live audio broadcast of the presentation or the subsequent archived recording, log onto http://www.istavision.com. Please connect to the website several minutes prior to the start of the webcast to ensure adequate time for any software download that may be necessary.

ABOUT ISTA PHARMACEUTICALS

ISTA Pharmaceuticals, Inc., is the fourth largest branded ophthalmic pharmaceutical business in the U.S. ISTA's four marketed products plus its product candidates include therapies for inflammation, ocular pain, allergy, glaucoma, and dry eye. The Company is developing a strong product pipeline to fuel future growth and market share. For additional information regarding ISTA, please visit ISTA Pharmaceuticals' website at http://www.istavision.com.


'/>"/>
SOURCE ISTA Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Watson Pharmaceuticals to Webcast Annual Meeting of Stockholders on May 7th
2. SynCo Expands Agreement with OncoMed Pharmaceuticals to Manufacture Cancer Stem Cell Antibodies
3. Cumberland Pharmaceuticals To Announce First Quarter 2010 Financial Results on May 13, 2010
4. Althea Technologies Acquires Altus Pharmaceuticals(R) Assets and IP Portfolio, Establishing Technology Platform for Protein Formulations.
5. Addex Pharmaceuticals to Present at BIO Business Forum During the Chicago BIO Convention, May 3rd - 6th, 2010
6. Savient Pharmaceuticals To Hold First Quarter 2010 Results
7. Ortho-McNeil-Janssen Pharmaceuticals, Inc. Resolves Investigation of Past TOPAMAX(R) Marketing and Promotional Activities
8. Lotus Pharmaceuticals Laevo-Bambuterol Received SFDA Approval to Commence Clinical Trials
9. Ortho-McNeil-Janssen Pharmaceuticals, Inc. Agrees to $75 Million Settlement for Topamax(R) False Claims Lawsuit
10. Renhuang Pharmaceuticals Announces Plans to Introduce Qing Re Jie Du Oral Liquid
11. Jazz Pharmaceuticals to Announce First Quarter 2010 Financial Results on May 5, 2010
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2016)... Feb. 8, 2016 http://www.researchandmarkets.com/research/x6mkjm/knee ... "Knee Reconstruction Devices Market by Product Type (Primary ... Geography (U.S., Canada, Eu-5, Japan, Bric, Turkey, Indonesia ... report to their offering. --> ... "Knee Reconstruction Devices Market by Product Type ...
(Date:2/8/2016)...  The University of Michigan Health System in ... part of the development of four new operating rooms, ... the U.S. to start using new top-of-the-line neurosurgical imaging ... of neurosurgery. --> Karin Muraszko , ... The BrightMatter technology from Synaptive Medical – a highly ...
(Date:2/8/2016)... DUBLIN , Feb. 8, 2016 /PRNewswire/ ... announced the addition of the "Label-Free ... Global Forecasts to 2020" report to ... has announced the addition of the ... - Global Forecasts to 2020" report ...
Breaking Medicine Technology:
(Date:2/8/2016)... (PRWEB) , ... February 08, 2016 , ... ... launched its newly redesigned website, federallabs.org . The site houses a wealth ... license available federal technologies through the process called technology transfer (T2). As a ...
(Date:2/8/2016)... ... February 08, 2016 , ... A man who has struggled to quit smoking, a ... Therapy , was determined to find solutions to his problems – and he did. Now ... is ready to introduce his breakthrough inventions to the world and better people's lives. ...
(Date:2/8/2016)... ... 08, 2016 , ... The Bell Agency, a full service ... of their ongoing community enrichment program. The current campaign fundraises for Angels & ... now being accepted at: http://www.angelsanddoves.com/donate.html . , Angels & Doves was founded ...
(Date:2/8/2016)... , ... February 08, 2016 , ... ... co-occur frequently. While a significant number of women and men with eating disorders ... trauma itself, that best predicts the development of an eating disorder. , ...
(Date:2/8/2016)... ... February 08, 2016 , ... TopConsumerReviews.com recently awarded their highest ... products. , Moles are derived from a cluster of melanin when exposed to sunlight. ... places and create a lifetime of embarrassment. Historically, mole removal has involved ...
Breaking Medicine News(10 mins):